Gallbladder bile composition in patients with Crohn's disease

World Journal of Gastroenterology

Volumn 12, Issue 1, 2006, Pages 70-74

  Lapidus, Annika ^a,b   Åkerlund, Jan Erik ^a,b   Einarsson, Curt ^a,b  

^a ERSTA HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bile acid; Biliary lipid composition; Bilirubin; Crohn's disease; Gallstone disease

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; AZATHIOPRINE; BILE ACID; BILIRUBIN; CHENODEOXYCHOLIC ACID; CHOLESTEROL; CHOLIC ACID; DEOXYCHOLIC ACID; LIPID; LITHOCHOLIC ACID; NITROIMIDAZOLE; STEROID; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; BILE COMPOSITION; CHOLESTEROL STONE; CLINICAL ARTICLE; CLINICAL TRIAL; COLITIS; COLON CROHN DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; CRYSTAL DEVELOPMENT TIME; CRYSTALLIZATION; FEMALE; GALLSTONE FORMATION; HEPATOBILIARY PARAMETERS; HIGH RISK PATIENT; HUMAN; HUMAN EXPERIMENT; ILEITIS; LIPID BILE LEVEL; MALE; NORMAL HUMAN; PATHOGENESIS; TIME; TREATMENT OUTCOME;

EID: 31144462886     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i1.70     Document Type: Article

References (33)

1. Cohen S, Kpplan M, Gottlieb L, Patterson J. Liver disease and gallstones in regional enteritis. Gastroenterology 1971; 60: 237-245
2. Harrower AD, Davidson NM, Yap PL, Nairn IM, Fyffe JA, Horn DB, Strong JA. Hypothalmic-pituitary adrenal responsiveness to dexamethasone-insulin tolerance test in acromegalic patients before and during treatment with bromocriptine. Acta Endocrinol (Copenh) 1978; 88: 18-22
3. Hill GL, Mair WSJ, Goligher JC. Gallstones after ileostomy and ileal resection. Gut 1975; 16: 932-936
4. Whorwell PJ, Hawkins R, Dewbury K, Wright R. Ultrasound survey of gallstones and other hepatobiliary disorders in patients with Crohn's disease. Dig Dis Sci 1984; 29: 930-933
5. Lourusso D, Leo S, Mossa A, Misciagna G, Guerra V. Cholelithiasis in inflammatory bowel disease; a case-control study. Dis Colon Rectum 1990; 33: 791-794
6. Hutchinson R, Tyrrell PNM, Kumar D, Dunn JA, Li JKW, Allan RN. Pathogenesis of gallstones in Crohn's disease: an alternative explanation. Gut 1994; 35: 94-97
7. Lapidus A, Baångstad M, ÅAstroöm M, Muhrbeck O. The prevalence of gallstone disease in a defined cohort of patients with Crohn's disease. Am J Gastroenterol 1999; 94: 1261-1266
8. Fraquelli M, Losco A, Viseutin S, Cesana BM, Pometta R, Colli A. Gallstone disease and related risk factors in patients with Crohn's disease: analysis of 330 consecutive cases. Arch Intern Med 2001; 161: 2201-2204
9. Magnuson TH, Lillemoe KD, Pitt HA. How many Americans will be eligible for biliary lithotripsy? Arch Surg 1989-1199; 124: Discussion1195-1199 1199-2000
10. Brink MA, Slors JFM, Keulemans YCA, Mok KS, Dde Waart DR, Carey MC, Groen AK, Tytgat GNJ. Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease. Gastroenterology 1999; 116: 1420-1427
11. Dowling RH, Bell DGD, White J. Lithogenic bile in patients with ileal dysfunction. Gut 1972; 13: 415-420
12. Marks JW, Conley DR, Capretta TL, Bonorris GG, Chung A, Coyne MJ, Schoenfield LJ. Gallstone prevalence and biliary lipid composition in inflammatory bowel disease. Am G Dig Dis Sci 1977; 22: 1097-1100
13. Rutgeerts P, Ghoos Y, Vantrappen G. Effects of partial ileocolectomy and Crohn's disease on biliary lipid secretion. Dig Dis Sci 1987; 32: 1231-1238
14. Pereira SP, Bain IM, Kumar D, Dowling RH. Bile composition in inflammatory bowel disease: ileal disease and colectomy but not colitis, induce lithogenic bile. Aliment Pharmacol Ther 2003: 17: 923-933
15. Faärkkilaä MA, Biliary cholesterol and lithogeniecity of bile in patients after ileal resection. Surgery 1988; 104: 18-25
16. Lapidus A, Einarsson K. Effects of ileal resection on biliary lipids and bile acid composition in patients with Crohn's disease. Gut 1991; 32: 1488-1491
17. Dawes L, Stryker S, Rege R, Nahrwold D. Gallbladder bile composition in Crohn's disease. Surg Forum 1991; 42: 188-189
18. Lapidus A, Einarsson C. Bile composition in patients with ileal resection due to Crohn's disease. Inflamm Bowel Dis 1998; 4: 89-94
19. Keulemans YCA, Mok KS, Slors JFM, Brink MA, Gouma DJ, Tytgat GNT, Groen AK. Concanavalin A-binding cholesterol crystallization inhibiting and promoting activity in bile from patients with Crohn's disease compared to patients with ulcerative colitis. J Hepatol 1999; 31: 685-691
20. Brink MA, Meéndez-Saánchez N, Carey MC. Bilirubin cycles enterohepatically after ileal resection in the rat. Gastroenterology 1996; 110: 1945-1957
21. Meéndez-Saánchez N, Brink MA, Paigen B, Carey MC. Ursodeoxycholic acid and cholesterol induce enterohepatic cycling of bilirubin in rodents. Gastroenterology 1998; 115: 722-732
22. Roda A, Festi D, Sama C, Mazzella G, Aldini RT, Roda E, Barbara L. Enzymatic determination of cholesterol in bile. Clin Chim Acta 1975; 64: 337-341
23. Rouser G, Fleischer S, Yamamoto A, Two dimensional thin-layer chromatographic separation of polar lipids and determination of phospholipids by phosphorous analysis of spots. Lipids 1970; 5: 494-496
24. Fausa O, Skålhegg BA. Quantitative determination of bile acids and their conjugates using thin-layer chromatography and a purified 3αlpha-hydroxysteroid dehydrogenase. Scand J Gastroenterol 1974; 9: 249-254
25. Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978; 19: 945-955
26. Angelin B, Einarsson K, Leijd B. Biliary lipid composition during treatment with different hypolipidaemic drugs. Eur J Clin Invest 1979; 9: 185-190
27. Holan KR, Holzbach RT, Hermann RE, Cooperman AM, Claffey WJ. Nucleating time: a key factor in pathogenesis of cholesterol gallstone disease. Gastroenterology 1979; 77: 611-617
28. Sahlin S, Ahlberg J, Angelin B, Reihneér E, Einarsson K. Nucleation time of gallbladder bile in gallstone patients-influence of bile acid treatment. Gut 1991; 32: 1554-1557
29. Keelan M, Thomson ABR. Feeding diets containing 2% chenoor ursodeoxycholic acid or cholestyramine to rats for two weeks alters intestinal morphology and bile acid absorption. Can J Phyacsiol Pharm 1991; 69: 592-598
30. Marteau P, Chazouilleres O, Myara A, Jian R, Rambaud JC, Poupon R. Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man. Hepatology 1990: 12: 1206-1208
31. Owen RW, Dodo M, Thompson MH, Hill MJ. Faecal steroid loss in healthy subjects during short-term treatment with ursodeoxycholic acid. J Steroid Biochem 1987; 26: 503-507
32. LESTERester R, SCHMIDchmid R. Intestinal absorption of bile pigments. II. Bilirubin absorption in man. N Engl J Med 1963; 269: 178-182
33. Neut C, Buliois P, Desreumaux P, Membreé J-M. Lederman E, Gambiez L, Cortot A, Quandalle P, van Kruiningen H, Colombel J-F. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am J Gastroenterol 2002; 97: 939-946